Significantly Enhances Firm’s Life Sciences Expertise and Service
Offerings
CHICAGO--(BUSINESS WIRE)--Oct. 3, 2012--
Navigant (NYSE: NCI) announced today that it has acquired the business
of Easton Associates (Easton), an international consulting firm
specializing in product and business strategy for companies in the life
sciences industries. The addition of more than 40 Easton professionals
creates a team of more than 90 total Navigant professionals focused on
services for the intensely competitive and highly regulated life
sciences industry. Easton professionals are based in several of
Navigant’s existing locations including New York, Chicago and London.
“This combination of two highly regarded firms in the life sciences
market adds new capabilities and scale to the benefit of our valued
clients,” said Eduardo Schur, Managing Director and leader of Navigant’s
Life Sciences practice. “Additionally, the combination of our talents in
concert with our Healthcare payer and provider practices will result in
a broad spectrum of services to address increased complexities in
pharmaceutical, biotech, medical device and diagnostic industries. Our
collective experience, innovative capacity and ability to understand
current and future trends will be a timely asset to our clients.”
Founded in 2000, Easton assists clients with business strategy
development, opportunity assessment, due diligence, R&D portfolio
management, new business planning, new product planning and related
issues. The significant expertise of Easton’s professionals, many of
whom have advanced degrees in medicine and pharmaceutical science, has
led to multiple longstanding client relationships with large
pharmaceutical firms, specialty pharmaceutical companies, biotech firms
and medical and diagnostic device companies.
“Innovation is a cornerstone of Easton’s philosophy,” said Kris Lowe,
Managing Director, Easton Associates. “Navigant shares that commitment
with Easton which made the firm a perfect fit for our Easton
professionals. Our entire senior management team feels that the
transition to Navigant is the right decision not only because the two
firms are complementary in the services that we provide, but also in the
shared vision of delivering excellence to our clients.”
No further details about the transaction were disclosed.
About Navigant Healthcare
Navigant Healthcare brings together more than 500 seasoned consulting
professionals and industry thought leaders who assist health systems,
physician organizations and payers in designing, developing and
implementing integrated solutions that create high-performing healthcare
organizations. Through a unique interdisciplinary approach leveraging
the depth and breadth of our experience as healthcare executives,
clinicians, and physicians, Navigant Healthcare enables clients to build
their capabilities and achieve sustainable peak performance around
quality of care, cost, leadership, and culture in today’s changing
healthcare environment. More information about Navigant Healthcare can
be found at www.navigant.com/healthcare.
Navigant’s Life Sciences practice is part of Navigant Healthcare and
assists global life sciences companies in gaining competitive advantage
by maximizing their business development, market access, strategic
marketing, marketing research, brand management, and pricing and
reimbursement initiatives. The team’s 90 consultants include healthcare
executives, clinicians and commercial leaders who develop innovative,
integrated custom solutions for global pharmaceutical, biotechnology,
medical device, diagnostic, biomarkers and drug delivery companies. More
information about Navigant Life Sciences can be found at www.navigant.com/lifesciences.
About Navigant
Navigant (NYSE: NCI) is a specialized, global expert services firm
dedicated to assisting clients in creating and protecting value in the
face of critical business risks and opportunities. Through senior level
engagement with clients, Navigant professionals combine technical
expertise in Disputes and Investigations, Economics, Financial Advisory
and Management Consulting, with business pragmatism in the highly
regulated Construction, Energy, Financial Services and Healthcare
industries to support clients in addressing their most critical business
needs. More information about Navigant can be found at www.navigant.com.
Source: Navigant
Navigant Healthcare Marketing
Mouzhan Mangum, 678.845.7640
or
Navigant
Investor Relations
Jennifer Moreno Reddick, 312.573.5634
